Myelodysplastic Syndrome: Signs That Might Deserve Medical Attention
Unexplained fatigue, frequent infections, or easy bruising can have many causes, but they may also point to changes in how the bone marrow makes blood cells. Myelodysplastic syndromes (MDS) are conditions that can disrupt healthy blood production, sometimes with subtle early signs. Knowing what to watch for can help you discuss concerns with a clinician sooner.
Small, ongoing changes—like feeling winded during routine chores or noticing bruises you can’t explain—often get attributed to stress, aging, or a busy schedule. When these changes come with unusual lab results or keep returning despite rest and time, they can be worth a closer look because they may reflect shifts in blood cell counts.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
What Is Myelodysplastic Syndrome?
Myelodysplastic syndromes (MDS) are a group of disorders in which the bone marrow does not make enough healthy, fully functioning blood cells. The marrow may produce blood-forming cells that are abnormal in size, shape, or maturity, and many of these cells may die before entering the bloodstream. The result can be persistently low levels of one or more blood cell types: red blood cells, white blood cells, and platelets.
MDS is typically suspected when routine blood work, often a complete blood count (CBC), shows cytopenias (low counts) that persist over time or do not match an obvious explanation. A clinician may also look at a peripheral blood smear, which can show whether cells appear unusually shaped or immature. If concern remains, diagnosis and classification commonly involve a bone marrow aspiration and biopsy, often paired with genetic or chromosome testing that helps describe the specific subtype and expected behavior.
Who Might Be at Higher Risk?
MDS can occur in adults of many ages, but it is more commonly diagnosed in older adults, so age is an important risk factor in the United States. Certain medical histories can also increase risk. For example, some people develop therapy-related MDS after prior chemotherapy or radiation therapy used for other cancers.
Environmental or workplace exposures have also been associated with bone marrow disorders in research. Long-term exposure to certain chemicals, such as benzene (historically linked to some industrial settings), is often discussed as a potential risk factor. Smoking has been associated with harmful chemical exposures as well. Having any risk factor does not mean someone will develop MDS; it simply means that persistent symptoms or abnormal blood counts may warrant a more careful evaluation rather than being dismissed as “normal.”
Symptoms That Might Be Easy to Overlook
Many early symptoms are tied to low blood counts and can feel nonspecific, especially when they develop gradually.
Low red blood cells (anemia) may cause fatigue, weakness, pale skin, headaches, dizziness, or shortness of breath with mild exertion (for example, climbing stairs). Some people notice reduced exercise tolerance long before they feel “sick.”
Low white blood cells—particularly neutrophils—can make infections more frequent or harder to clear. This may show up as recurring sinus or respiratory infections, fevers without a clear source, gum infections, or skin infections.
Low platelets can affect clotting, leading to easy bruising, prolonged bleeding from small cuts, nosebleeds, bleeding gums, heavier-than-usual menstrual bleeding, or petechiae (tiny red or purple dots on the skin that can look like a rash). These signs deserve attention when they are new for you, worsening, or occurring together.
Why Can MDS Be Difficult to Detect?
MDS is often difficult to detect early because many symptoms overlap with far more common conditions. Fatigue and anemia can be caused by iron deficiency, vitamin B12 or folate deficiency, chronic inflammation, kidney disease, thyroid disease, or medication effects. Frequent infections can reflect diabetes, chronic lung disease, immune-suppressing medications, or simple exposure patterns. Easy bruising can be influenced by aspirin and other blood-thinning medications, supplements, liver disease, or platelet function issues.
Another reason is that some people feel well despite abnormal counts, particularly if changes occur slowly and the body compensates. Clinicians often evaluate trends: a single low count might be repeated, while persistent or progressive changes across multiple cell lines can prompt a more extensive workup.
When a clinician suspects a bone marrow production problem, they may order additional tests beyond the CBC, such as reticulocyte count, iron studies, B12 and folate levels, markers of inflammation, and sometimes tests for hemolysis (premature breakdown of red blood cells). A bone marrow biopsy may be recommended when there is unexplained, ongoing cytopenia or when blood smear findings suggest abnormal development of blood cells.
How Does MDS Affect Blood Cell Production?
In healthy bone marrow, stem cells mature into red blood cells, several types of white blood cells, and platelets in a tightly regulated process. In MDS, that process becomes inefficient and dysplastic, meaning developing cells may form with abnormalities and fail to mature correctly. Even if the marrow appears “busy,” many cells may be defective or die early, so fewer functional cells reach circulation.
The impact depends on which cell types are most affected:
Red blood cell shortages reduce oxygen delivery to tissues, often driving fatigue, shortness of breath, and lightheadedness.
White blood cell shortages reduce immune defenses, raising the risk of infections and sometimes blunting typical infection signals.
Platelet shortages weaken clotting, increasing the likelihood of bruising and bleeding.
Because MDS includes multiple subtypes, the course can vary significantly. Some cases remain relatively stable for a long time with careful monitoring, while others progress more quickly or evolve into acute myeloid leukemia (AML). For this reason, classification often includes marrow findings and genetic/chromosomal information, which help clinicians assess risk and tailor management.
Practical warning signs that may deserve medical attention include persistent fatigue paired with documented anemia, recurrent infections or unexplained fevers, unusual bruising or bleeding, and abnormal blood counts that do not improve after addressing common causes (such as correcting an identified iron or vitamin deficiency). Symptoms such as chest pain, fainting, severe shortness of breath, black or bloody stools, or uncontrolled bleeding should generally be treated as urgent reasons to seek prompt care.
In summary, MDS is a bone marrow disorder that can reduce the body’s supply of healthy blood cells, and its early signals may be subtle or mistaken for more common problems. Understanding the patterns—especially when symptoms persist or cluster with abnormal lab results—can support timely clinical evaluation and appropriate next steps.